Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes

Human Molecular Genetics

Volumn 22, Issue 11, 2013, Pages 2283-2292

  Cortes, Adrian ^a   Field, Judith ^b   Glazov, Evgeny A ^a   Hadler, Johanna ^a   Stankovich, Jim ^c   Brown, Matthew A ^a   Baxter, Alan ^d   Kermode, Allan G ^e   Taylor, Bruce ^c   Booth, David R ^f   Mason, Deborah ^g   Stewart, Graeme J ^f   Butzkueven, Helmut ^b   Charlesworth, Jac ^c   Wiley, James ^b   Lechner Scott, Jeannette ^h   Tajouri, Lotti ⁱ   Griffiths, Lyn ^j   Slee, Mark ^k   Moscato, Pablo ^h   Scott, Rodney J ^h   Broadley, Simon ^j   Vucic, Steve ^f   Kilpatrick, Trevor J ^b   Carroll, William M ^e   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d JAMES COOK UNIVERSITY   (Australia)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^h HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

ⁱ BOND UNIVERSITY   (Australia)

^j GRIFFITH UNIVERSITY   (Australia)

^k FLINDERS UNIVERSITY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 27B1; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CHROMOSOME 12Q13-14; CHROMOSOME ABERRATION; CHROMOSOME MAP; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE NUMBER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEXT GENERATION SEQUENCING; NIMBLEGEN SOLUTION PHASE HYBRIDIZATION CAPTURE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84877898509     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt062     Document Type: Article

References (49)

1. Compston, A. and Coles, A. (2008) Multiple sclerosis. Lancet, 372, 1502-1517.
2. Oksenberg, J.R. and Barcellos, L.F. (2005) Multiple sclerosis genetics: leaving no stone unturned. Genes Immun., 6, 375-387.
3. Sadovnick, A.D., Ebers, G.C., Dyment, D.A. and Risch, N.J. (1996) Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet, 347, 1728-1730.
4. Bertrams, J. and Kuwert, E. (1972) HL-A antigen frequencies in multiple sclerosis. Significant increase of HL-A3, HL-A10 and W5, and decrease of HL-A12. Eur. Neurol., 7, 74-78.
5. Naito, S., Namerow, N., Mickey, M.R. and Terasaki, P.I. (1972) Multiple sclerosis: association with HL-A3. Tissue Antigens, 2, 1-4.
6. Ebers, G.C. (2008) Environmental factors and multiple sclerosis. Lancet Neurol., 7, 268-277.
7. Islam, T., Gauderman, W.J., Cozen, W., Hamilton, A.S., Burnett, M.E. and Mack, T.M. (2006) Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann. Neurol., 60, 56-64.
8. Pierrot-Deseilligny, C. and Souberbielle, J.C. (2010) Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain, 133, 1869-1888.
9. Hafler, D.A., Consortium, I.M.S.G., Compston, A., Sawcer, S., Lander, E.S., Daly, M.J., Jager, P.L.D., de Bakker, P.I.W., Gabriel, S.B., Mirel, D.B. et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med., 357, 851-862.
10. Wellcome Trust Case Control Consortium & Australo-Anglo-American Spondylitis Consortium (TASC) (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet., 39, 1329-1337.
11. Baranzini, S.E., Wang, J., Gibson, R.A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.-W., Lindberg, R.L.P., Uitdehaag, B.M.G., Johnson, M.R. et al. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Genet., 18, 767-778.
12. Jager, P.L.D., Jia, X., Wang, J., de Bakker, P.I.W., Ottoboni, L., Aggarwal, N.T., Piccio, L., Raychaudhuri, S., Tran, D., Aubin, C. et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet., 41, 776-782.
13. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet., 41, 824-828.
14. Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C.C., Patsopoulos, N.A., Moutsianas, L., Dilthey, A., Su, Z., Freeman, C., Hunt, S.E. et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature, 476, 214-219.
15. Adorini, L. and Penna, G. (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol., 4, 404-412.
16. Boonstra, A., Barrat, F.J., Crain, C., Heath, V.L., Savelkoul, H.F. and O'Garra, A. (2001) 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol., 167, 4974-4980.
17. Penna, G. and Adorini, L. (2000) 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol., 164, 2405-2411.
18. Ramos-Lopez, E., Bruck, P., Jansen, T., Pfeilschifter, J.M., Radeke, H.H. and Badenhoop, K. (2007) CYP2R1-, CYP27B1- and CYP24-mRNA expression in German type 1 diabetes patients. J. Steroid Biochem. Mol. Biol., 103, 807-810.
19. Ramos-Lopez, E., Kahles, H., Weber, S., Kukic, A., Penna-Martinez, M., Badenhoop, K. and Louwen, F. (2008) Gestational diabetes mellitus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms. Diabetes Obes. Metab., 10, 683-685.
20. Ramagopalan, S.V., Dyment, D.A., Cader, M.Z., Morrison, K.M., Disanto, G., Morahan, J.M., Berlanga-Taylor, A.J., Handel, A., De Luca, G.C., Sadovnick, A.D. et al. (2011) Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann. Neurol., 70, 881-886.
21. Ishida, T., Kobayashi, N., Tojo, T., Ishida, S., Yamamoto, T. and Inoue, J. (1995) CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth. J. Immunol., 155, 5527-5535.
22. Marzo, N., Ortega, S., Stratmann, T., Garcia, A., Rios, M., Gimenez, A., Gomis, R. and Mora, C. (2008) Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model. J. Immunol., 180, 1189-1198.
23. Sekine, C., Sugihara, T., Miyake, S., Hirai, H., Yoshida, M., Miyasaka, N. and Kohsaka, H. (2008) Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors. J. Immunol., 180, 1954-1961.
24. Zhernakova, A., Stahl, E.A., Trynka, G., Raychaudhuri, S., Festen, E.A., Franke, L., Westra, H.J., Fehrmann, R.S., Kurreeman, F.A., Thomson, B. et al. (2011) Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet., 7, e1002004.
25. Satoh, J.-i., Nakanishi, M., Koike, F., Onoue, H., Aranami, T., Yamamoto, T., Kawai, M., Kikuchi, S., Nomura, K., Yokoyama, K. et al. (2006) T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. J. Neuroimmunol., 174, 108-118.
26. Raychaudhuri, S., Remmers, E.F., Lee, A.T., Hackett, R., Guiducci, C., Burtt, N.P., Gianniny, L., Korman, B.D., Padyukov, L., Kurreeman, F.A. et al. (2008) Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet., 40, 1216-1223.
27. Gandhi, K.S., McKay, F.C., Cox, M., Riveros, C., Armstrong, N., Heard, R.N., Vucic, S., Williams, D.W., Stankovich, J., Brown, M. et al. (2010) The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum. Mol. Genet., 19, 2134-2143.
28. Calvo, S.E., Tucker, E.J., Compton, A.G., Kirby, D.M., Crawford, G., Burtt, N.P., Rivas, M., Guiducci, C., Bruno, D.L., Goldberger, O.A. et al. (2010) High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat. Genet., 42, 851-858.
29. Bentley, D.R., Balasubramanian, S., Swerdlow, H.P., Smith, G.P., Milton, J., Brown, C.G., Hall, K.P., Evers, D.J., Barnes, C.L., Bignell, H.R. et al. (2008) Accurate whole human genome sequencing using reversible terminator chemistry. Nature, 456, 53-59.
30. Mamanova, L., Coffey, A.J., Scott, C.E., Kozarewa, I., Turner, E.H., Kumar, A., Howard, E., Shendure, J. and Turner, D.J. (2010) Target-enrichment strategies for next-generation sequencing. Nat. Methods, 7, 111-118.
31. Rivas, M.A., Beaudoin, M., Gardet, A., Stevens, C., Sharma, Y., Zhang, C.K., Boucher, G., Ripke, S., Ellinghaus, D., Burtt, N. et al. (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet., 43, 1066-1073.
32. Cortes, A. and Brown, M.A. (2011) Promise and pitfalls of the Immunochip. Arthritis Res. Ther., 13, 101.
33. Gabriel, S., Ziaugra, L. and Tabbaa, D. (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr. Protoc. Hum. Genet., Chapter 2, Unit 2, 12.
34. Spencer, C.C.A., Su, Z., Donnelly, P. and Marchini, J. (2009) Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet., 5, e1000477.
35. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
36. Nejentsev, S., Walker, N., Riches, D., Egholm, M. and Todd, J.A. (2009) Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science, 324, 387-389.
37. Montgomery, S.B., Sammeth, M., Gutierrez-Arcelus, M., Lach, R.P., Ingle, C., Nisbett, J., Guigo, R. and Dermitzakis, E.T. (2010) Transcriptome genetics using second generation sequencing in a Caucasian population. Nature, 464, 773-777.
38. McKenzie, C.A., Abecasis, G.R., Keavney, B., Forrester, T., Ratcliffe, P.J., Julier, C., Connell, J.M., Bennett, F., McFarlane-Anderson, N., Lathrop, G.M. et al. (2001) Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum. Mol. Genet., 10, 1077-1084.
39. Frere, C., Tregouet, D.A., Morange, P.E., Saut, N., Kouassi, D., Juhan-Vague, I., Tiret, L. and Alessi, M.C. (2006) Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study. Blood, 108, 1562-1568.
40. Zaitlen, N., Pasaniuc, B., Gur, T., Ziv, E. and Halperin, E. (2010) Leveraging genetic variability across populations for the identification of causal variants. Am. J. Hum. Genet., 86, 23-33.
41. Udler, M.S., Meyer, K.B., Pooley, K.A., Karlins, E., Struewing, J.P., Zhang, J., Doody, D.R., MacArthur, S., Tyrer, J., Pharoah, P.D. et al. (2009) FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum. Mol. Genet., 18, 1692-1703.
42. International HapMap Consortium (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851-861.
43. Out, A.A., van Minderhout, I.J., Goeman, J.J., Ariyurek, Y., Ossowski, S., Schneeberger, K., Weigel, D., van Galen, M., Taschner, P.E., Tops, C.M. et al. (2009) Deep sequencing to reveal new variants in pooled DNA samples. Hum. Mutat., 30, 1703-1712.
44. Bansal, V., Tewhey, R., Leproust, E.M. and Schork, N.J. (2011) Efficient and cost effective population resequencing by pooling and in-solution hybridization. PLoS One, 6, e18353.
45. Li, Y., Willer, C.J., Ding, J., Scheet, P. and Abecasis, G.R. (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol., 34, 816-834.
46. Li, H. and Durbin, R. (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 25, 1754-1760.
47. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G. and Durbin, R. (2009) The sequence alignment/ Map format and SAMtools. Bioinformatics, 25, 2078-2079.
48. McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A.,Garimella,K., Altshuler, D.,Gabriel, S.,Daly,M. et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res., 20, 1297-1303.
49. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.